XLON
EDEN
Market cap19mUSD
Jul 10, Last price
2.90GBP
1D
1.75%
1Q
-10.77%
Jan 2017
-74.74%
IPO
-85.11%
Name
Eden Research PLC
Chart & Performance
P/E
—
P/S
3.48
EPS
—
Div Yield, %
—
Shrs. gr., 5y
20.66%
Rev. gr., 5y
18.71%
Revenues
4m
+34.79%
Net income
-2m
L-70.64%
CFO
-1m
L-40.51%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1995 and headquartered in Abingdon, UK, Eden Research plc specializes in delivering sustainable products for crop protection, animal well-being, and consumer markets throughout the United Kingdom and wider European region. Its agricultural offerings encompass treatments for foliar diseases and insect control, applications for both open fields and greenhouses, soil pest management, methods to extend post-harvest freshness, and seed enhancements. For animal health, the company provides companion animal care items, bio-control agents, parasite remedies, and insect repellent sprays. Additionally, Eden Research produces human health and consumer goods, including head lice treatments, fragrances, deodorants, wound care solutions, food flavorings, odor neutralizers, and supplies of active ingredients.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||